Steamboat Springs, Colorado. January 15-18, 2016

Transcription

1 Friday, January 15, 2016 Registration: Begins at 2:00 pm Plenary Session: 4:00 pm - 6:00 pm 14 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 15-18, 2016 Current Status and Future Directions of Checkpoint Blockade Immunotherapy Across Tumor Types Patrick Hwu, MD Nanoparticle Therapy: Ready for Prime Time? Steven A. Curley, MD Pros and Cons of Proton Therapy: Worth the Expense or Just Expensive? Andrew K. Lee, MD Next Generation of Phase 1 Drug Development Based on Biomarker Discovery Funda Meric-Bernstam, MD Are Ascopal Effects Reproducible or Just Anecdotal? Stephen Hahn, MD Disease Site Session I: Thoracic 6:10-9:00pm Moderator: Stephen G. Swisher, MD SBRT for Early Stage NSCLC: Does the Data Support a Change in the Standard of Care? David C. Rice, MD Targeted Therapy for Unresectable Lung Cancer: Current Status and Future Directions John V. Heymach, MD, PhD Organ Preservation in Locally Advanced Esophageal Cancer: Is This a Realistic Goal? Wayne L. Hofstetter, MD

2 Application of Robotic Surgery in Thoracic Oncology Reza J. Mehran, MD Moderator: Stephen G. Swisher, MD Panel: All Speakers and Quynh Nhu Nguyen, MD Welcome Reception: 9:00-10:00 pm Saturday, January 16, 2016 Disease Site Session II: Cutaneous Oncology 6:45 am - 9:15 am Managing SLN Positive Melanoma: Is it Time to Abandon Completion Lymph Node Dissections? Jeffrey E. Gershenwald, MD Systemic Therapy for High Risk Melanoma: Adjuvant or Neo-adjuvant? Kenneth F. Grossmann, MD, PhD Disseminated BRAF Mutated Melanoma: Should Targeted Therapy be First Line? Patrick Hwu, MD Is There a Future for Intralesional Therapy in Advanced Melanoma? Robert H. Andtbacka, MD Panel: All Speakers; Joel Claveau, MD; Ana M. Ciurea, MD; Victor G. Prieto, MD, PhD Meet the Professor: 9:30 am -11:45 am Disease Site Session III: Breast Oncology 4:30 pm - 7:30 pm Moderator: Kelly K. Hunt, MD Genetic Testing: Appropriate Candidates AndIimplications for Prophylaxis and Breast Cancer Treatment* Jennifer Litton, MD Evolving Techniques in the Surgical Management of the Regional Nodes Kelly K. Hunt, MD

3 Nodal Basin Irradiation: Local Regional Disease Control or Survival Benefit? Thomas A. Buchholz, MD Advances and Controversies in Breast Reconstruction David M. Adelman, MD, PhD What s New in Triple Negative and Inflammatory Breast Cancer Management? Immunotherapy for Breast Cancer: Vaccines and Evolving Strategies Elizabeth A. Mittendorf, MD, PhD Moderator: Kelly K. Hunt, MD Panel: All Speakers and Aysegul A. Sahin, MD Sunday, January 17, 2016 Disease Site Session IV: Urology 7:00 am -9:30 am Moderator: Christopher G. Wood, MD Debate # 1: Neoadjuvant Chemotherapy For ct2 Bladder Cancer Pro: Neema Nava, MD Con: Jay B. Shah, MD Debate # 2: Lymph Node Dissection Is a Necessary Part of a Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma Pro: Bradley C. Leibovich, MD Con: Jose A. Karam, MD Neoadjuvant Therapy for Locally Advanced Prostate Cancer: Current Status In 2016 Brian F. Chapin, MD Immune Therapy for Bladder Cancer Neema Navai, MD

4 Moderator: Christopher G. Wood, MD Panel: Brian F. Chapin, MD; Jose A. Karam, MD; Bradley C. Leibovich, MD; Neema Navai, MD; Jay B. Shah, MD; Nizar M. Tannir, MD Meet the Professor 9:30 am-11:30 am Disease Site Session V: GI Malignancies 4:30pm-7:30pm Moderator: Robert A. Wolff, MD Adjuvant Therapy for Colorectal Cancer: Current Controversies Minimally Invasive Surgical Approaches to Rectal Cancer: Oncologically Safe? Brian K. Bednarski, MD Surgery for Colorectal Liver Metastases: Are the Indications Expanding? Steven A. Curley, MD Novel Molecular Signatures in Pancreas Cancer: Implications for Prognosis and Treatment Jason B. Fleming, MD Systemic Therapy for Resectable Pancreas Cancer: Adjuvant or Neo-adjuvant? Robert A. Wolff, MD New Frontiers in Radiation Therapy for GI Malignancies Christopher Crane, MD Moderator: Robert A. Wolff, MD Panel: All Speakers Monday, January 18, :30am-10:30am HPV symposium: From the Oris to the Anus Moderator: Erich M. Sturgis, MD Prognosis and Treatment of HPV Head and Neck Cancer Erich M. Sturgis, MD Cervical Cancer: Public Health Issues and Vaccines* Kathleen M. Schmeler, MD

5 Anal Cancer: Current Approaches and Future Directions Multi-modality Treatment for Ovarian Cancer: Current Controversies Michael Frumovitz, MD Outcomes, Toxicity, and Palliative care Moderator: Brian D. Badgwell Integrating Cancer Cpecific Outcomes Measures into Practice* Karl Bilimoria, MD Enhanced Recovery after Thoracic Surgery* Reza J. Mehran, MD Novel Approaches to Lymphedema* Edward I. Chang, MD Diagnosis and Management of Dermatologic Toxicity of Novel Targeted and Immune Therapies Joel Claveau, MD Palliative Care Symposium Novel Approaches to Pain Management* Radiation Therapy of Bone Metastases* Quynh-Nhu Nguyen, MD Palliative Surgery: How to Measure Success* Brian D. Badgwell, MD ADJOURNMENT *Presentations are appropriate for ethics credit